|
Volumn 51, Issue 5, 2005, Pages
|
Post-marketing study to assess the safety, tolerability and effectiveness of Fungisome™: An Indian liposomal amphotericin B preparation
a
KEM HOSPITAL
(India)
|
Author keywords
Fungisome ; Liposomal amphotericin B; Post marketing; Systemic fungal infections
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
ANTIANEMIC AGENT;
CREATININE;
FUNGISOME;
HYDROCORTISONE;
PHENIRAMINE;
POTASSIUM CHLORIDE;
UNCLASSIFIED DRUG;
ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD;
ADULT;
ANTIMICROBIAL THERAPY;
APNEA;
ASPERGILLOSIS;
BRONCHOSPASM;
CALCULATION;
CANDIDIASIS;
CLINICAL PRACTICE;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CRYPTOCOCCOSIS;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG COST;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG INFUSION;
DRUG MARKETING;
DRUG SAFETY;
DRUG TOLERABILITY;
FEBRILE NEUTROPENIA;
FEMALE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPOKALEMIA;
INDIA;
INFORMATION PROCESSING;
INFORMED CONSENT;
MAJOR CLINICAL STUDY;
MALE;
MENINGITIS;
MUCORMYCOSIS;
MYCOSIS;
PATIENT ASSESSMENT;
PHYSICIAN;
POSTMARKETING SURVEILLANCE;
POTASSIUM BLOOD LEVEL;
PRESCRIPTION;
RETROSPECTIVE STUDY;
REVIEW;
SIDE EFFECT;
STATISTICAL ANALYSIS;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
ADULT;
AMPHOTERICIN B;
ANTIFUNGAL AGENTS;
FEMALE;
FEVER;
HUMANS;
INDIA;
LIPOSOMES;
MALE;
MYCOSES;
NEUTROPENIA;
PRODUCT SURVEILLANCE, POSTMARKETING;
RETROSPECTIVE STUDIES;
|
EID: 33645544381
PISSN: 00223859
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (20)
|
References (11)
|